ROCK SPRINGS CAPITAL MANAGEMENT LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | MLTX | 28K | $202.19K |
 | PRTA | 25K | $247.88K |
 | CGEN | 13K | $19.74K |
 | REGN | 11K | $6.35M |
 | PCVX | 11K | $399.82K |
 | TMO | 10K | $4.85M |
 | WST | 10K | $2.56M |
 | CRL | 3K | $422.44K |
MoonLake Immunotherapeutics
MLTX
Shares Held
28K
Value
$202.19K
Prothena Corporation plc
PRTA
Shares Held
25K
Value
$247.88K
Compugen Ltd.
CGEN
Shares Held
13K
Value
$19.74K
Regeneron Pharmaceuticals, Inc.
REGN
Shares Held
11K
Value
$6.35M
Vaxcyte, Inc.
PCVX
Shares Held
11K
Value
$399.82K
Thermo Fisher Scientific Inc.
TMO
Shares Held
10K
Value
$4.85M
West Pharmaceutical Services, Inc.
WST
Shares Held
10K
Value
$2.56M
Charles River Laboratories International, Inc.
CRL
Shares Held
3K
Value
$422.44K